Smart ring maker Oura announced on Thursday that it has closed a $200 million Series D funding round, bringing the company’s valuation to $5.2 billion. The round included participation from Fidelity Management and glucose device maker Dexcom.

After years of wearable technology companies eating each other, Oura has been a huge beacon of success. And the company is now looking at new products, amid a huge new injection of cash and stonking valuation.

Finnish health tech firm Oura has closed a $200M Series D funding round that boosts its market valuation to $5.2B. The smart ring maker secured investments from Fidelity Management & Research Company and Dexcom (NASDAQ:DXCM) that will allow it to expand its product offerings and further invest in product,

Founded in 2013, Oura makes a wearable smart ring that contains a number of on-board sensors track a users’ heart rate, breathing regularity, body temperature, blood oxygen and sleep patterns. Using data from these metrics,